HARPREET SHELLER: Open Payments
NPI 1407426695 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 34 payments from 10 companies in 2025. Trend: 2023 $252 · 2024 $869 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $208 |
| Merck Sharp & Dohme LLC | 7 | $174 |
| Novo Nordisk Inc | 4 | $101 |
| PFIZER INC. | 4 | $84 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 7 | $54 |
| Baxter Healthcare | 1 | $34 |
| Alnylam Pharmaceuticals Inc. | 2 | $29 |
| Boston Scientific Corporation | 1 | $24 |
| Amgen Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: INJECTAFER, VERQUVO, Wegovy, VYNDAQEL, LifeVest, Hillrom - Cardiac Ambulatory Monitor, AMVUTTRA, CAPVAXIVE.
Industry payments across CA — which companies pay providers there.
